Insulin degludec

德谷胰岛素

Report date: 2026/05/20 20:02:01

Base Information

Drug NameInsulin degludec
Drug Alias Name地谷胰岛素Insulin decludecSIBAinsulinum degludecuminsulina degludec +[11] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryJapan
Original Approved Date2012/09/28
Country/TerritoryFormer Serbia and MontenegroCzechiaBelgium +[49] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityNovo Nordisk A/S
Inactive CompaniesNovo Nordisk (China)Pharmaceuticals Co Ltd
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AE06
Related LinksWikipediaDrugBankKEGG